Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WDAY vs MRNA✓SelectedUSD · MRNAWDAY vs MRNA performance historyLatest closeAs of-2.30%11/19
Stock and ETF performance explorer

WDAY vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+8.1%
MRNA return
+806.0%
Excess return
-798.0%
Maximum drawdown
-63.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.3%+1.3%-3.6%-2.4%
7D-9.1%-13.8%+4.8%-8.4%
30D-15.0%-17.7%+2.6%-14.4%
3M-12.6%+14.3%-26.9%-13.9%
6M+34.0%+336.0%-301.9%+16.9%
YTD-19.3%+575.9%-595.2%-32.9%
1Y-22.6%+724.4%-746.9%-36.8%
3Y-25.2%+160.8%-185.9%-35.0%
5Y-39.5%-24.4%-15.1%-44.3%
All+8.1%+806.0%-798.0%-14.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling